BioScrip Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
SunTrust Downgrades BioScrip (BIOS) to Neutral
August 11, 2015 7:15 AM EDTSunTrust Robinson Humphrey downgraded BioScrip (NASDAQ: BIOS) from Buy to Neutral with a price target of $2.00 (from $5.00).
For an analyst ratings summary and ratings history on BioScrip click here. For more ratings news on BioScrip click here.
Shares of BioScrip closed at $2.08 yesterday.
... MoreBioScrip (BIOS) Posts Q2 GAAP Loss of $3.60/Share; Will Review Strategic Alternatives
August 10, 2015 7:06 AM EDTBioScrip (NASDAQ: BIOS) reported Q2 EPS of ($3.60), which may not compare with the analyst estimate of ($0.08). Revenue for the quarter came in at $262.4 million versus the consensus estimate of $269.38 million.
Consolidated Adjusted EBITDA was a loss of $2.5 million, a $13.5 million decrease compared to Adjusted EBITDA of $11.0 million in the prior year period. The decrease was primarily due to a lower gross margin revenue mix shift as well as the increase of contractual and bad debt expense; and
BioScrip announced a multi-step plan to enhance shareholder value, improve financial flexibility and position... More
